Searchable abstracts of presentations at key conferences in endocrinology

ea0026p491 | Thyroid cancer | ECE2011

Factors connected with the female sex – association with differentiated thyroid cancer

Przybylik-Mazurek E P M , Hubalewska-Dydejczyk A H D , Fedorowicz A F , Pach D P

Differentiated thyroid cancer (DTC) is more frequent in women than in men.The aim of the study was to analyze whether factors connected with the female sex could increase the risk of DTC.Material and methods: Ninety nine patients with a mean age±S.D. of 40.5±5.9 years with DTC and 51 healthy women with a mean age of 36.52±8.3 years were examined. Gynecological and obstetric histories were taken and ser...

ea0026p725 | Diabetes (epidemiology, pathophysiology) | ECE2011

Risk factors of conversion from IGT and IFG to diabetes type 2

Piwonska-Solska B P S , Pach D P , Gilis-Januszewska A G J , Hubalewska-Dydejczyk A H D

Objective: To determine the predictive risk factors for the development of type 2 diabetes mellitus (DM) in patients with impaired glucose tolerance (IGT) or impaired fasting glucose (IFG) during the 8.5 follow up.Research design and methods: This is an 8-year prospective study in a randomly selected urban population including 2838 subjects aged ≥40 years living in Krakow. Seven hundred and six had IGT (387) or IFG (319) based on WHO criteria and 2...

ea0026p76 | Endocrine tumours and neoplasia | ECE2011

Management of type III neuroendocrine tumors of the stomach

Gilis-Januszewska A G J , Baczynska E B , Sowa-Staszczak A S S , Trofimiuk M T , Pach D P , Tomaszewska R T , Hubalewska-Dydejczyk A H D

Background: Type 3 neuroendocrine tumors of the stomach (type 3 NETV) are very rare subtypes of NETV with poor prognosis, not fully understood biology and not well investigated diagnostic and therapeutic procedures. The aim of the study was to analyze tumor biology and the outcome of differentiated treatment in patients with type 3 neuroendocrine tumors of the stomach.Methods: A prospective 10 years follow up of five patients with type 3 NETV treated in ...

ea0026p77 | Endocrine tumours and neoplasia | ECE2011

Could 99mTc labeled long-acting agonist of GLP-1 (Exendin-4) scintigraphy be a new tool in the diagnostics of unknown focus of insulinoma ? preliminary results

Hubalewska-dydejczyk A H D , Pach D P , Sowa-Staszczak A S S , Jabrocka-Hybel A J H , Stefanska A S , Gilis-Januszewska A G J , Mikolajczak R M , Janota B J

Introduction: GLP-1 receptors have been fund on different types of neoplasmÂ’ cells and density of these receptors appears to be more frequent in some of them. GLP-1 receptor scanning offers a new approach for successful localization of small or not detectable by other methods insulinomas and other cancers such as MTC, gastrinoma, pheochromocytoma, gastrinoma, etc.Aim of the study: The aim of study was to present first successful experiences with the...